$4.34 +0.11 (%) Achillion Pharmaceuticals Inc - NASDAQ

Dec. 9, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Will These 5 Drug Stocks Be Big Winners This Earnings Season?

    TalkMarkets | Oct. 13, 2016 | 10:54AM EST
  2. Achillion Names Dr. Joel Barrish as Chief Scientific Officer

    Benzinga | Jan. 4, 2016 | 06:21AM EST
  3. Najarian Brothers Are Bullish On American Airlines And Achillion Pharma

    Benzinga | Dec. 31, 2015 | 08:20AM EST
  4. Achillion Announces Upcoming Oral Presentation and Nomination of ACH-4471 at #ASH2015

    Benzinga | Dec. 6, 2015 | 08:38AM EST
  5. Achillion Announces Janssen Initiated Phase 2a Study to Evaluate Combination of AL-335, ACH-3102, and Simeprevir for Treatment of Genotype 1 Chronic HCV

    Benzinga | Oct. 16, 2015 | 05:07AM EST
  6. UBS: Biotech Will Continue To Outperform In 2015

    Benzinga | Sep. 8, 2015 | 12:22PM EST
  7. Morning Market Gainers

    Benzinga | Sep. 8, 2015 | 08:45AM EST
  8. Benzinga's Top #PreMarket Gainers

    Benzinga | Sep. 8, 2015 | 07:15AM EST
  9. Achillion to Present at Baird, Morgan Stanley Conferences

    Benzinga | Sep. 1, 2015 | 05:57AM EST
  10. Achillion Announces Janssen Initiated Phase I Study to Evaluate Effect of Simeprevir and Odalasvir on AL-335 Pharmacokinetics

    Benzinga | Aug. 3, 2015 | 03:20AM EST
  11. Gilead Q2 Earnings Soar As HCV Shines, HIV Rebounds

    IBD | Jul. 28, 2015 | 15:34PM EST
  12. What Will Gilead Buy Next? 4 Possible Targets

    IBD | Jul. 15, 2015 | 15:44PM EST
  13. Where Can Mega-Drug Stock Gilead Sciences Go Now?

    IBD | Jun. 22, 2015 | 12:56PM EST
  14. Morning Market Losers

    Benzinga | Jun. 22, 2015 | 08:49AM EST
  15. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 22, 2015 | 07:19AM EST
  16. UBS and JMP Securities Downgrade Achillion Pharmaceuticals Inc. ...

    GuruFocus | May. 21, 2015 | 17:41PM EST
  17. What Does The Johnson & Johnson/Achillion Deal Mean For HCV Competitors?

    Benzinga | May. 21, 2015 | 07:27AM EST
  18. Achillion

    IBD | May. 20, 2015 | 17:39PM EST
  19. Dycom Industries (DY) Surpasses Estimates; Achillion Pharma (ACHN) Inks Mega-Deal with Janssen

    GuruFocus | May. 20, 2015 | 16:12PM EST
  20. Achillion Dives As J&J Hep C Deal Chills Buyout Buzz

    IBD | May. 20, 2015 | 12:52PM EST
  21. Morning Market Losers

    Benzinga | May. 20, 2015 | 08:56AM EST
  22. Benzinga's Top Downgrades

    Benzinga | May. 20, 2015 | 08:46AM EST
  23. JMP Securities Downgrades Achillion Pharmaceuticals To Market Perform

    Benzinga | May. 20, 2015 | 08:04AM EST
  24. JMP Says Stepping To The Sidelines On Achillion

    Benzinga | May. 20, 2015 | 07:54AM EST
  25. ACHILLION PHARMA

    IBD | May. 19, 2015 | 17:30PM EST
  26. Achillion, J&J To Jointly Develop Hepatitis C Drugs

    IBD | May. 19, 2015 | 16:07PM EST
  27. Morning Market Losers

    Benzinga | May. 19, 2015 | 08:49AM EST
  28. Benzinga's Top #PreMarket Losers

    Benzinga | May. 19, 2015 | 07:15AM EST
  29. Momo, Take-Two, Urban Outfitters Lead Monday's After-Hours Movers

    Benzinga | May. 18, 2015 | 17:47PM EST
  30. After-Hours Movers Led By Bob Evans, Bazaarvoice And Smith & Wesson On Tuesday

    Benzinga | Mar. 3, 2015 | 17:58PM EST
  31. Top 5 Biotech Stocks That The Smart Money Doesn't Like

    Benzinga | Feb. 17, 2015 | 12:17PM EST
  32. US Stock Futures Up Ahead Of Jobless Claims, Retail Sales Data

    Benzinga | Feb. 12, 2015 | 07:30AM EST
  33. Morning Market Losers

    Benzinga | Feb. 11, 2015 | 10:00AM EST
  34. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 11, 2015 | 08:25AM EST
  35. JMP Securities Covers Mostly Good News From Pharma Pending More Visibility

    Benzinga | Feb. 11, 2015 | 07:54AM EST
  36. Achillion Pharmaceuticals Stock Soars Following Successful Mid-Stage Hep C Drug Combo Trial

    GuruFocus | Feb. 10, 2015 | 12:36PM EST
  37. Morning Market Gainers

    Benzinga | Feb. 9, 2015 | 09:48AM EST
  38. Achillion Pharmaceuticals Shares Surge On Positive Data

    Benzinga | Feb. 9, 2015 | 09:34AM EST
  39. Monday Morning Movers: Achillion Up, Regulus Down Following Drug Results

    Benzinga | Feb. 9, 2015 | 09:05AM EST
  40. Benzinga's Top #PreMarket Gainers

    Benzinga | Feb. 9, 2015 | 08:07AM EST
  41. HCV Stocks Struggle As Gilead, Merck Face Headwinds

    IBD | Feb. 4, 2015 | 12:12PM EST
  42. Worst Performing Industries For February 4, 2015

    Benzinga | Feb. 4, 2015 | 11:05AM EST
  43. What Investors Are Watching For In Regulus Therapeutics' Next Data Release

    Benzinga | Jan. 30, 2015 | 14:32PM EST
  44. Deutsche Bank's Top Biotech Picks For 2015

    Benzinga | Jan. 22, 2015 | 11:09AM EST
  45. Hall of Fame/ Hall of Shame: The Best and Worst Recommendations of 2014

    GuruFocus | Jan. 9, 2015 | 10:25AM EST
  46. The Top 5 Biotech Gainers Of 2014

    Benzinga | Dec. 29, 2014 | 14:15PM EST
  47. Morning Market Movers

    Benzinga | Dec. 29, 2014 | 09:51AM EST
  48. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 29, 2014 | 08:04AM EST
  49. Morning Market Movers

    Benzinga | Dec. 24, 2014 | 09:42AM EST
  50. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 24, 2014 | 08:09AM EST
Trading Center